Cargando…

Predicted savings to the UK National Health Service from switching to generic antiretrovirals, 2014–2018

INTRODUCTION: In other disease areas, generic drugs are normally used after patent expiry. Patents on zidovudine, lamivudine, nevirapine and efavirenz have already expired. Patents will expire for abacavir in late 2014, lopinavir/r in 2016, and tenofovir, darunavir and atazanavir in 2017. However, p...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hill, Andrew, Hill, Teresa, Jose, Sophie, Pozniak, Anton
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	International AIDS Society 2014
Materias:	Oral Presentation – Abstract O216
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4224875/ https://www.ncbi.nlm.nih.gov/pubmed/25394006 http://dx.doi.org/10.7448/IAS.17.4.19497

Ejemplares similares

PACIENTES COM LEUCEMIA MIELOIDE CRÔNICA E SARS-COV-2: REVISÃO SISTEMÁTICA
por: Silva, W.R., et al.
Publicado: (2020)

Troubles anxiodépressifs chez le personnel de santé impliqué dans la riposte au Covid-19 à Douala
por: Endale Mangamba, L.M., et al.
Publicado: (2022)

Large disparities in HIV treatment cascades between eight European and high-income countries – analysis of break points
por: Raymond, Alice, et al.
Publicado: (2014)

An outbreak of infective endocarditis during the COVID-19 pandemic? - an observational retrospective single centre study
por: Cabral, M, et al.
Publicado: (2021)

Life expectancy of HIV-1-positive individuals approaches normal conditional on response to antiretroviral therapy: UK Collaborative HIV Cohort Study
por: May, M, et al.
Publicado: (2012)

Clinical pharmacokinetics of antiretroviral drugs in Ugandan patients
por: Lamorde, M
Publicado: (2012)

Evolution of resistance in paediatric patients with failure on antiretroviral therapy
por: Orrell, C, et al.
Publicado: (2012)

Use of deep sequencing data for routine analysis of HIV resistance in newly diagnosed patients
por: Fernández-Caballero, Jose-Angel, et al.
Publicado: (2014)

Enhanced normalisation of CD4/CD8 ratio with early antiretroviral therapy in primary HIV infection
por: Thornhill, John, et al.
Publicado: (2014)

Does pregnancy increase the risk of ART-induced hepatotoxicity among HIV-positive women?
por: Huntington, Susie, et al.
Publicado: (2014)

Efavirenz- but not nevirapine-based antiretroviral therapy decreases exposure to the levonorgestrel released from a sub-dermal contraceptive implant
por: Scarsi, Kimberly, et al.
Publicado: (2014)

Effectiveness of a reduced dose of efavirenz plus 2 NRTIs as maintenance antiretroviral therapy with the guidance of therapeutic drug monitoring
por: Yang, Shang-Ping, et al.
Publicado: (2014)

Effects of age on symptom burden, mental health and quality of life amongst people with HIV in the UK
por: McGowan, Jennifer, et al.
Publicado: (2014)

Musculoskeletal service transformation in a post-Covid world as part of the creation of a new city-wide single hospital service
por: Reid, D.
Publicado: (2022)

Physiotherapy staff experiences during COVID-19: A service evaluation, framework analysis and recommendations for a future physiotherapy service
por: James, S., et al.
Publicado: (2022)

Rate of viral load failure over time in people on ART in the UK Collaborative HIV Cohort (CHIC) study
por: O'Connor, Jemma, et al.
Publicado: (2014)

Are new antiretroviral treatments increasing the risks of clinical obesity?
por: Hill, Andrew, et al.
Publicado: (2019)

The Ethics of Switch/Simplify in Antiretroviral Trials: Non-Inferior or Just Inferior?
por: Carr, Andrew, et al.
Publicado: (2012)

Embracing digital technology in response to the COVID - 19 pandemic: A patient satisfaction service evaluation
por: Hadley-Barrows, T., et al.
Publicado: (2022)

A retrospective review of the use of text message communication for a musculoskeletal service during COVID-19
por: Waters, L., et al.
Publicado: (2022)

A service evaluation of remote consultation mediums in a physiotherapy department during the COVID-19 pandemic
por: Harlington, S., et al.
Publicado: (2022)

Antiretroviral generics
por: Andrieu, Véronique
Publicado: (2012)

Safety profile of HIV-1 attachment inhibitor prodrug BMS-663068 in antiretroviral-experienced subjects: week 24 analysis
por: Lalezari, Jacob, et al.
Publicado: (2014)

HIV-1 attachment inhibitor prodrug BMS-663068 in antiretroviral-experienced subjects: week 24 sub-group analysis
por: Brinson, Cynthia, et al.
Publicado: (2014)

The PROTEA trial: darunavir/ritonavir with or without nucleoside analogues, for patients with HIV-1 RNA below 50 copies/mL
por: Antinori, Andrea, et al.
Publicado: (2014)

When could new antiretrovirals be recommended for national treatment programmes in low-income and middle-income countries: results of a WHO Think Tank
por: Vitoria, Marco, et al.
Publicado: (2017)

When to start: as soon as possible
por: Saag, M
Publicado: (2012)

When to start: not so fast
por: Lundgren, J
Publicado: (2012)

Late presenters: what can we do?
por: Mussini, C
Publicado: (2012)

TB and HIV: how can we reduce mortality?
por: Lawn, S
Publicado: (2012)

HIV drug resistance surveillance in low- and middle-income countries: 2004 to 2010
por: Bertagnolio, S, et al.
Publicado: (2012)

Treatment optimization in low- and middle-income countries
por: Cooper, D
Publicado: (2012)

HIV, co-morbidity and ageing
por: Reiss, P
Publicado: (2012)

Antiviral activity of dolutegravir in subjects with failure on an integrase inhibitor-based regimen: week 24 phase 3 results from VIKING-3
por: Nichols, G, et al.
Publicado: (2012)

Does early initiation of ART in infants affect virological and resistance outcomes? Data from the CHER trial after 6 years of follow-up
por: Violari, A, et al.
Publicado: (2012)

Eliminating paediatric infections and keeping mothers alive
por: Gray, G
Publicado: (2012)

Review of life expectancy in people with HIV in settings with optimal ART access: what we know and what we don't
por: Sabin, C
Publicado: (2012)

HIV in women
por: Mulcahy, F
Publicado: (2012)

Currently available medications may not be sufficient for lifelong treatment of HIV
por: Jansson, J, et al.
Publicado: (2012)

HAART rollout in the new fiscal and economic environment
por: Moatti, J
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_mo72ei91f8ucp4dqot1mh77a3c